Alterations of calcium channels and cell excitability in intracardiac ganglion neurons from type 2 diabetic rats

American Journal of Physiology - Cell Physiology

Volumn 302, Issue 8, 2012, Pages

  Liu, Jinxu ^a   Tu, Huiyin ^a   Zheng, Hong ^a   Zhang, Libin ^a   Tran, Thai P ^a   Muelleman, Robert L ^a   Li, Yu Long ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Action potential; Intracardiac ganglia; Rat; Type 2 diabetes mellitus

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL N TYPE; OMEGA CONOTOXIN; STREPTOZOCIN;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; GANGLION; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; INTRACARDIAC GANGLION NERVE CELL; LIPID DIET; MOUSE; NERVE CELL EXCITABILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ARTERIES; BAROREFLEX; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; GANGLIA; HEART; MALE; NEURONS; OMEGA-CONOTOXIN GVIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 84859783063     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00315.2011     Document Type: Article

References (57)

1. Ai J, Epstein PN, Gozal D, Yang B, Wurster R, Cheng ZJ. Morphology and topography of nucleus ambiguus projections to cardiac ganglia in rats and mice. Neuroscience 149: 845-860, 2007.
2. Armour JA. Intrinsic cardiac neurons. J Cardiovasc Electrophysiol 2: 331-341, 1991.
3. Armour JA. Myocardial ischaemia and the cardiac nervous system. Cardiovasc Res 41: 41-54, 1999.
4. Armour JA. Potential clinical relevance of the 'little brain' on the mammalian heart. Exp Physiol 93: 165-176, 2008.
5. Benarroch EE. Neuronal voltage-gated calcium channels: brief overview of their function and clinical implications in neurology. Neurology 74: 1310-1315, 2010.
6. Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16: 521-555, 2000.
7. Chang CJ, Yang YC, Lu FH, Lin TS, Chen JJ, Yeh TL, Wu CH, Wu JS. Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med 123: 432-438, 2010.
8. Chen HS, Hwu CM, Kuo BI, Chiang SC, Kwok CF, Lee SH, Lee YS, Weih MJ, Hsiao LC, Lin SH, Ho LT. Abnormal cardiovascular reflex tests are predictors of mortality in Type 2 diabetes mellitus. Diabet Med 18: 268-273, 2001.
9. Cheng Z, Powley TL. Nucleus ambiguus projections to cardiac ganglia of rat atria: an anterograde tracing study. J Comp Neurol 424: 588-606, 2000.
10. Cheng Z, Zhang H, Guo SZ, Wurster R, Gozal D. Differential control over postganglionic neurons in rat cardiac ganglia by NA and DmnX neurons: anatomical evidence. Am J Physiol Regul Integr Comp Physiol 286: R625-R633, 2004.
11. Cheng Z, Zhang H, Yu J, Wurster RD, Gozal D. Attenuation of baroreflex sensitivity after domoic acid lesion of the nucleus ambiguus of rats. JAppl Physiol 96: 1137-1145, 2004.
12. Cuevas J, Adams DJ. M4 muscarinic receptor activation modulates calcium channel currents in rat intracardiac neurons. J Neurophysiol 78: 1903-1912, 1997.
13. Expert Committee on the Diagnosis, and Classification of Diabetes Mel- litus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26, Suppl 1: S5-S20, 2003.
14. Flanagan AM, Brown JL, Santiago CA, Aad PY, Spicer LJ, Spicer MT. High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J Nutr Biochem 19: 505-513, 2008.
15. Freccero C, Svensson H, Bornmyr S, Wollmer P, Sundkvist G. Sympathetic and parasympathetic neuropathy are frequent in both type 1 and type 2 diabetic patients. Diabetes Care 27: 2936-2941, 2004.
16. Ganguly PK, Beamish RE, Dhalla KS, Innes IR, Dhalla NS. Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol Endocrinol Metab 252: E734-E739, 1987.
17. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 21: 1138-1145, 1998.
18. Head J, Fuller JH. International variations in mortality among diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 33: 477-481, 1990.
19. Hogg RC, Trequattrini C, Catacuzzeno L, Petris A, Franciolini F, Adams DJ. Mechanisms of verapamil inhibition of action potential firing in rat intracardiac ganglion neurons. J Pharmacol Exp Ther 289: 1502-1508, 1999.
20. Horackova M, Armour JA. Role of peripheral autonomic neurones in maintaining adequate cardiac function. Cardiovasc Res 30: 326-335, 1995.
21. Jeong SW, Wurster RD. Calcium channel currents in acutely dissociated intracardiac neurons from adult rats. J Neurophysiol 77: 1769-1778,1997.
22. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol 128: 389-401, 1988.
23. Kusakabe T, Tanioka H, Ebihara K, Hirata M, Miyamoto L, Miyanaga F, Hige H, Aotani D, Fujisawa T, Masuzaki H, Hosoda K, Nakao K. Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet. Diabetologia 52: 675-683, 2009.
24. Lebovitz HE. Insulin resistance-a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 8: 237-249, 2006.
25. Lebovitz HE, Banerji MA. Treatment of insulin resistance in diabetes mellitus. Eur J Pharmacol 490: 135-146, 2004.
26. Li YL, Zheng H. Angiotensin II-NADPH oxidase-derived superoxide mediates diabetes-attenuated cell excitability of aortic baroreceptor neurons. Am J Physiol Cell Physiol 301: C1368-C1377, 2011.
27. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 19881992, 1993.
28. Lund DD, Subieta AR, Pardini BJ, Chang KS. Alterations in cardiac parasympathetic indices in STZ-induced diabetic rats. Diabetes 41: 160-166, 1992.
29. Luo J, Quan J, Tsai J, Hobensack CK, Sullivan C, Hector R, Reaven GM. Nongenetic mouse models of non-insulin-dependent diabetes melli-tus. Metabolism 47: 663-668, 1998.
30. Miller AW, Sims JJ, Canavan A, Hsu T, Ujhelyi MR. Impaired vagal reflex activity in insulin-resistant rats. J Cardiovasc Pharmacol 33: 698-702, 1999.
31. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates. Diabetologia 33: 538-541, 1990.
32. Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, Moller DE, Thornberry NA, Zhang BB. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. Diabetes 55: 1695-1704, 2006.
33. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123-131, 1987.
34. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76: 44-48, 1993.
35. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49: 1390-1394, 2000.
36. Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22: 485-518, 1970.
37. Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism 56: 1233-1240, 2007.
38. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 1661-1669, 1996.
39. Sampaio KN, Mauad H, Spyer KM, Ford TW. Differential chronotropic and dromotropic responses to focal stimulation of cardiac vagal ganglia in the rat. Exp Physiol 88: 315-327, 2003.
40. Sanya EO, Brown CM, Dutsch M, Zikeli U, Neundorfer B, Hilz MJ. Impaired cardiovagal and vasomotor responses to baroreceptor stimulation in type II diabetes mellitus. Eur J Clin Invest 33: 582-588, 2003.
41. Srinivasan K, Patole PS, Kaul CL, Ramarao P. Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 26: 327-333, 2004.
42. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 125: 451-472, 2007.
43. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52: 313-320, 2005.
44. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol Endocrinol Metab 251: E576-E583, 1986.
45. Takahashi N, Anan F, Nakagawa M, Yufu K, Ooie T, Nawata T, Shigematsu S, Hara M, Saikawa T, Yoshimatsu H. Microalbuminuria, cardiovascular autonomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus. Metabolism 53: 1359-1364, 2004.
46. Takahashi N, Nakagawa M, Saikawa T, Ooie T, Yufu K, Shigematsu S, Hara M, Sakino H, Katsuragi I, Okeda T, Yoshimatsu H, Sakata T. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol 38: 232-237, 2001.
47. Tanaka S, Hayashi T, Toyoda T, Hamada T, Shimizu Y, Hirata M, Ebihara K, Masuzaki H, Hosoda K, Fushiki T, Nakao K. High-fat diet impairs the effects of a single bout of endurance exercise on glucose transport and insulin sensitivity in rat skeletal muscle. Metabolism 56: 1719-1728, 2007.
48. Tsien RW, Lipscombe D, Madison D, Bley K, Fox A. Reflections on Ca(2+)-channel diversity, 1988-1994. TrendsNeurosci 18: 52-54, 1995.
49. Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 11: 431-438, 1988.
50. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915, 1990.
51. Weir GC, Clore ET, Zmachinski CJ, Bonner-Weir S. Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes 30: 590-595, 1981.
52. Whyte KA, Hogg RC, Dyavanapalli J, Harper AA, Adams DJ. Reactive oxygen species modulate neuronal excitability in rat intrinsic cardiac ganglia. Auton Neurosci 150: 45-52, 2009.
53. Xu ZJ, Adams DJ. Resting membrane potential and potassium currents in cultured parasympathetic neurones from rat intracardiac ganglia. J Physiol 456: 405-424, 1992.
54. Xu ZJ, Adams DJ. Voltage-dependent sodium and calcium currents in cultured parasympathetic neurones from rat intracardiac ganglia. J Physiol 456: 425-441, 1992.
55. Zhang H, Cuevas J. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87: 2867-2879, 2002.
56. Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008: 704045, 2008.
57. Zhang T, Pan BS, Zhao B, Zhang LM, Huang YL, Sun FY. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains. Neuroscience 161: 1045-1056, 2009.